Bachem Peptide Synthesis: How the Swiss CDMO Makes Peptides

Bachem peptide synthesis is the process by which Bachem Holding AG, a Swiss contract development and manufacturing organization (CDMO), builds peptides for research, clinical trials, and commercial drug products. The company uses solid-phase peptide synthesis and related techniques to assemble amino acid chains, then purifies and tests them under GMP conditions. Bachem supplies peptide active pharmaceutical ingredients (APIs) and research-grade peptides to laboratories and drug developers — it does not sell finished prescription medicine to consumers.

What Bachem Peptide Synthesis Actually Involves

Peptides are short chains of amino acids, and building them reliably at scale is harder than it sounds. Most Bachem peptide synthesis starts with solid-phase peptide synthesis (SPPS), in which amino acids are attached one at a time to a resin-bound chain.

Every coupling step has to be efficient. A 30-amino-acid peptide involves roughly 30 coupling and deprotection cycles, and small errors compound with each round.

• Coupling and deprotection: amino acids are added in sequence, with protecting groups removed between steps.
• Cleavage: the finished chain is released from the resin.
• Purification: reverse-phase HPLC separates the target peptide from truncated or misfolded byproducts.
• Analytics: mass spectrometry, HPLC, and amino acid analysis confirm identity and purity.
• Lyophilization: the peptide is dried into a stable powder for storage and shipping.

Longer or unusually difficult sequences may use fragment condensation or native chemical ligation instead of straight SPPS. Bachem also manufactures oligonucleotides and other complex molecules, but peptides remain its core business.

From Research Scale to Commercial Supply

The same chemistry runs at very different volumes. Bachem peptide manufacturing spans laboratory research quantities up to multi-ton commercial supply, and the equipment, documentation, and cost profile change at every step.

Scale	Typical quantity	Who buys it	Documentation level
Research	Milligrams to a few grams	Academic labs, discovery groups	Certificate of analysis
Preclinical and clinical	Grams to kilograms	Biotech and pharma developers	GMP batch records, stability data
Commercial	Hundreds of kilograms to tons	Approved drug manufacturers	Full regulatory filing support

Scale-up is where many peptide projects stall. A route that works in a fume hood may not transfer to a thousand-liter reactor, which is why CDMOs invest heavily in process development before any commercial commitment.

Custom Peptide Synthesis and CDMO Services

Bachem custom peptide synthesis covers made-to-order sequences, modifications, conjugates, and labeled peptides. Most of that work is confidential, and customers range from small academic groups to large pharmaceutical companies.

As a CDMO, Bachem also carries the regulatory load that comes with drug development:

• Process development and scale-up
• Analytical method development and validation
• GMP manufacturing for clinical and commercial supply
• Stability studies and documentation for regulatory filings

The bachem company has been manufacturing peptides since 1971 and is headquartered in Bubendorf, Switzerland, with sites in Europe, the United States, and Israel. That history matters to buyers because switching a peptide supplier late in development is slow, expensive, and heavily regulated.

Bachem Peptides, Tirzepatide, and GLP-1 Demand

Search interest in bachem peptides tirzepatide reflects the broader boom in GLP-1 drugs. Tirzepatide and semaglutide are peptides, and demand for them has strained global peptide manufacturing capacity.

Bachem has publicly expanded peptide capacity to serve this category, and large drugmakers rely on a mix of in-house and external manufacturing. A CDMO that produces a peptide API is not the same as a pharmacy that dispenses a prescription product, and the two are regulated in completely different ways.

This distinction is the single most common source of confusion for people researching Bachem online. Bachem is a supplier to the pharmaceutical industry, not a retail seller of weight-loss medication.

What Peptide Synthesis Costs and Why Quotes Vary

Peptide pricing depends on sequence length, purity, quantity, modifications, and documentation requirements. There is no meaningful flat rate for custom work.

A bachem peptide calculator is something people search for when they want a quick cost estimate before contacting a supplier. Most CDMOs, including Bachem, quote custom projects individually instead of publishing per-milligram prices.

Cost drivers typically include:

1. Number of amino acids and sequence difficulty
2. Purity target, such as crude versus 95% or 98%
3. Quantity, since larger batches spread fixed costs
4. Research grade versus GMP-grade manufacturing
5. Timeline, including rush delivery

Quotes also reflect the paperwork. GMP production requires validated methods, batch records, and quality review that research-grade synthesis never touches, so the price gap between the two is often large.

Bachem vs. Online Research Peptide Vendors

Much of the interest in Bachem comes from people who previously bought from consumer-facing research-peptide websites. The two business models are not comparable.

Factor	Bachem	Typical online research-peptide seller
Business model	Contract manufacturing (CDMO)	Direct-to-consumer retail
Main customers	Pharma, biotech, academic labs	Individual buyers
Quality documentation	GMP records, audits, regulatory filings	Often a simple certificate of analysis
Purchasing process	Quotes, contracts, account setup	Online checkout
Regulatory status	Inspected API manufacturer	Research-use-only labeling

Conversations about peptide sciences shut down illustrate how quickly the gray-market supply of research peptides can change. When a consumer vendor disappears, buyers often look for a supplier that seems more legitimate and land on a CDMO website — but Bachem is not a replacement for that kind of retail purchase.

Research-grade peptides sold for laboratory use are not FDA-approved drugs and are not intended for human consumption.

Bachem operates under GMP expectations and is inspected by regulators, but that does not mean every product it makes is approved for human use. Anyone considering a peptide for a health condition should talk with a licensed healthcare professional rather than self-sourcing material online.

COMMON QUESTIONS

Frequently Asked Questions

Is Bachem a legitimate peptide manufacturer?

Yes. Bachem Holding AG is a publicly traded Swiss company founded in 1971 that manufactures peptides and oligonucleotides under GMP for pharmaceutical, biotech, and research customers. It supplies APIs and custom peptides to drug developers rather than selling finished medicine to consumers.

Can I buy peptides directly from Bachem?

Bachem sells research-grade peptides and custom synthesis services mainly to institutions and companies, usually through a quote and account setup rather than a consumer checkout. Prescription products like tirzepatide cannot be purchased from Bachem by individuals and require a prescription from a licensed healthcare professional.

How does Bachem compare with vendors like Peptide Sciences?

Peptide Sciences was a consumer-facing research-peptide retailer, while Bachem is a GMP contract manufacturer serving the pharmaceutical industry. They are not substitutes for each other: one sold small research quantities online, and the other manufactures peptide APIs for regulated drug supply chains.